Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Medication Index

View All
Tegretol
Temazepam Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Switching to Longer-Acting Benzodiazepines to Taper Temazepam When and Why to Stop Gabapentinoids Benzodiazepines Solutions and suspensions Tapering When and Why to Stop Benzodiazepines and Z-Drugs Z drugs (benzodiazepine receptor agonists)
Tofranil
Tranylcypromine Antidepressants Mis-Diagnosis of Withdrawal Effects As Relapse Recent Developments in the Understanding of Antidepressant Withdrawal Tapering Factors Influencing Development of Withdrawal Effects Phenelzine Solutions and suspensions Tranylcypromine
Tranylcypromine Sulfate
Trazodone Dilutions Managing Complications of Antidepressant Discontinuation Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Solutions and suspensions Trazodone Antidepressants Factors Influencing Development of Withdrawal Effects Other Considerations in Tapering Benzodiazepines and Z-Drugs Receptor occupancy, Tapering
Triazolam Benzodiazepines Receptor occupancy, Switching to Longer-Acting Benzodiazepines to Taper The Neurobiology of Tapering Withdrawal Symptoms During Benzodiazepine Maintenance Treatment Management of Complications of Benzodiazepine and Z-Drug Discontinuation Solutions and suspensions Tapering Triazolam Z drugs (benzodiazepine receptor agonists)
Trimipramine Factors Influencing Development of Withdrawal Effects Stratfiying Risk of Antidepressant Withdrawal
Tranxene
Trazodone Hydrochloride